RPG Life Sciences 

₹2,810
4
-₹8.8-0.31% Thursday 09:59

统计数据

当日最高
2,873.95
当日最低
2,780
52周最高
2,974.95
52周最低
1,292
成交量
18,843
平均成交量
60,718
市值
46.62B
市盈率
50.59
股息收益率
0.57%
股息
16

即将到来

股息

0.57%股息收益率
10年增长
29.57%
5年增长
46.14%
3年增长
30.5%
1年增长
33.33%

收益

31Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
999
333
-333
-999
预期每股收益
N/A
实际每股收益
N/A

人们还关注

此列表基于关注RPGLIFE.NSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Show more...
首席执行官
Mr. Yugal Kishor Choturam Sikri
员工
1270
国家
IN
ISIN
INE105J01010

上市公司